Small-Cell Prostate Cancer Variety Surprisingly Common
- PMID: 30072408
- DOI: 10.1158/2159-8290.CD-NB2018-101
Small-Cell Prostate Cancer Variety Surprisingly Common
Abstract
A recent study finds that treatment-emergent small-cell neuroendocrine prostate cancer occurs in 17% of patients with the metastatic, castration-resistant form of the disease. This small-cell variety of prostate cancer shows a distinct gene expression signature and reduces patients' survival by nearly 20%.
©2018 American Association for Cancer Research.
Comment on
-
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.J Clin Oncol. 2018 Aug 20;36(24):2492-2503. doi: 10.1200/JCO.2017.77.6880. Epub 2018 Jul 9. J Clin Oncol. 2018. PMID: 29985747 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources